These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 6747937)
1. Response from women to adverse publicity about oral contraceptives. Portnoy A J R Coll Gen Pract; 1984 Jun; 34(263):334-5. PubMed ID: 6747937 [TBL] [Abstract][Full Text] [Related]
2. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. Rosenberg MJ; Waugh MS; Long S J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875 [TBL] [Abstract][Full Text] [Related]
3. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
4. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
5. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL; Peterson HB Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918 [TBL] [Abstract][Full Text] [Related]
6. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects. United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093 [TBL] [Abstract][Full Text] [Related]
11. The pill and cancer--IPPF response. IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693 [TBL] [Abstract][Full Text] [Related]
12. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study. Hannaford PC; Kay CR Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398 [TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
14. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [TBL] [Abstract][Full Text] [Related]
15. OCs are currently the second most popular birth control method in U.S. Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916 [TBL] [Abstract][Full Text] [Related]
16. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304 [TBL] [Abstract][Full Text] [Related]
17. Dispelling OC myths and misperceptions. Grimes DA Dialogues Contracept; 1994; 4(3):1-4. PubMed ID: 12345574 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and MI: how strong is the link? Jick H J Cardiovasc Med; 1982 May; 7(5):481, 484-5. PubMed ID: 12311565 [TBL] [Abstract][Full Text] [Related]
19. [Use of oral contraceptives and smoking among Danish women]. Obel EB Ugeskr Laeger; 1993 Nov; 155(44):3537. PubMed ID: 8236573 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]